Cargando…
Two Blood Monocytic Biomarkers (CCL15 and p21) Combined with the Mini-Mental State Examination Discriminate Alzheimer's Disease Patients from Healthy Subjects
BACKGROUND: Alzheimer's disease (AD) is a progressive neurodegenerative disorder. In AD, monocytes migrate across the blood-brain barrier and differentiate into microglia, are linked to inflammatory responses and display age-dependent decreases in telomere lengths. METHODS: Six monocyte-specifi...
Autores principales: | Hochstrasser, Tanja, Marksteiner, Josef, Defrancesco, Michaela, Deisenhammer, Eberhard A., Kemmler, Georg, Humpel, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235941/ https://www.ncbi.nlm.nih.gov/pubmed/22545041 http://dx.doi.org/10.1159/000330468 |
Ejemplares similares
-
Telomere length is age-dependent and reduced in monocytes of Alzheimer patients
por: Hochstrasser, Tanja, et al.
Publicado: (2012) -
Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer’s disease
por: Marksteiner, Josef, et al.
Publicado: (2022) -
Changes in White Matter Integrity before Conversion from Mild Cognitive Impairment to Alzheimer’s Disease
por: Defrancesco, Michaela, et al.
Publicado: (2014) -
Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer’s disease
por: Marksteiner, Josef, et al.
Publicado: (2017) -
The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment
por: Klavins, Kristaps, et al.
Publicado: (2015)